Enes with the differentiation program of myogenic cells. Adv Cancer Res 1987, 49:1?8. 87. Haltmeier H, Rohrer H: Distinct and different effects of the oncogenes vmyc and v-src on avian sympathetic neurons: retroviral transfer of v-myc stimulates neuronal proliferation whereas v-src transfer enhances neuronal differentiation. J Cell Biol 1990, 110:2087?098. 88. Hecker G, Lewis DL, Rausch DM, Jelsema CL: Nerve-growth-factor-treated and v-src-expressing PC 12 cells: a model for neuronal differentiation. Biochem Soc Trans 1991, 19:385?86. 89. Tatosyan AG, Mizenina OA: Kinases of the Src family: structure and functions. Biochemistry (Mosc) 2000, 65:49?8. 90. Grant SG, O’Dell TJ, Karl KA, Stein PL, Soriano P, Kandel ER: Impaired longterm potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science 1992, 258:1903?910. 91. Grant SG, Silva AJ: Targeting learning. Trends Neurosci 1994, 17:71?5. 92. HMPL-013 web Kojima N, Wang J, Mansuy IM, Grant SG, Mayford M, Kandel ER: Rescuing impairment of long-term potentiation in fyn-deficient mice by introducing Fyn transgene. Proc Natl Acad Sci U S A 1997, 94:4761?765. 93. Maness PF: Nonreceptor protein tyrosine kinases associated with neuronal development. Dev Neurosci 1992, 14:257?70. 94. Sinai L, Duffy S, Roder JC: Src inhibition reduces NR2B surface expression and synaptic plasticity in the amygdala. Learn Mem 2010, 17:364?71. 95. PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/28404814 Tremblay MA, Acker CM, Davies P: Tau phosphorylated at tyrosine 394 is found in Alzheimer’s disease tangles and can be a product of the Ablrelated kinase, Arg. J Alzheimers Dis 2011, 19:721?33. 96. Jing Z, Caltagarone J, Bowser R: Altered subcellular distribution of c-Abl in Alzheimer’s disease. J Alzheimers Dis 2009, 17:409?22. 97. Vazquez MC, Vargas LM, Inestrosa NC, Alvarez AR: c-Abl modulates AICD dependent cellular responses: transcriptional induction and apoptosis. J Cell Physiol 2009, 220:136?43. 98. Tremblay MA, Acker CM, Davies P: Tau phosphorylated at tyrosine 394 is found in Alzheimer’s disease tangles and can be a product of the Ablrelated kinase, Arg. J Alzheimers Dis 2010, 19:721?33. 99. Imam SZ, Zhou Q, Yamamoto A, Valente AJ, Ali SF, Bains M, Roberts JL, Kahle PJ, Clark RA, Li S: Novel regulation of parkin function through c-Ablmediated tyrosine phosphorylation: implications for Parkinson’s disease. J Neurosci 2011, 31:157?63.100. Ko HS, Lee Y, Shin JH, Karuppagounder SS, Gadad BS, Koleske AJ, Pletnikova O, Troncoso JC, Dawson VL, Dawson TM: Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin’s ubiquitination and protective function. Proc Natl Acad Sci U S A 2010, 107:16691?6696. 101. Lebouvier T, Scales TM, Williamson R, Noble W, Duyckaerts C, Hanger DP, Reynolds CH, Anderton BH, Derkinderen P: The microtubule-associated protein tau is also phosphorylated on tyrosine. J Alzheimers Dis 2009, 18:1?. 102. Cancino GI, Perez De Arce K, Castro PU, Toledo EM, Von Bernhardi R, Alvarez AR: c-Abl tyrosine kinase modulates tau pathology and Cdk5 phosphorylation in AD transgenic mice. Neurobiol Aging 2011, 32:1249?261. 103. Shah NP, Tran C, Lee FY, Chen P, Norris D, Sawyers CL: Overriding imatinib resistance with a novel ABL kinase inhibitor. Science 2004, 305:399?01. 104. Sawyers CL: Chronic myeloid leukemia. N Engl J Med 1999, 340:1330?340.doi:10.1186/1742-2094-9-117 Cite this article as: Dhawan and Combs: Inhibition of Src kinase activity attenuates amyloid associated microgliosis in a murine model of Alzheimer’s disease. Journal of Neu.